ribociclib
novartis
['bcsm', 'natalee', 'breast', ' ribo', 'ribociclib']
first results of the natalee trial, on ribociclib as adjuvant option in early #breastcancer. primary endpoint was met: idfs (hr 0.75, p 0.0014), consistent in all subgroups #asco23 #bcsm 
Physician scientist, Breast Oncology @CroAviano, @Uniud, @LiquidBioTeam, @CtcLaboratory. #TranslationalResearch, #PrecisionMedicine, Mac Geek, Ramen Addicted.